“…Considering population-based studies in which HC2 testing was used, the HC2-positive prevalence of 7.1% in our study is comparable to the reported prevalence from countries in Europe and North America (6.3-8.1%) (Cuzick et al, 2003;Leinonen et al, 2008;Castle et al, 2009;Ogilvie et al, 2012;Zorzi et al, 2013), while it is higher than the prevalence in the Netherlands (4.5%) (Bulkmans et al, 2007) but is lower than that in India (10.3-16.2%) (Sankaranarayanan et al, 2009;Pandey et al, 2012;Rai et al, 2014) and China (9.9-27.5%) (Zhao et al, 2010;Li et al, 2013). Population-based studies for HPV detection by PCR techniques also have demonstrated high overall HPV prevalence in Latin America and Africa, where cervical cancer incidence is high (Herrero et al, 2000;Franceschi et al, 2006).…”